Canterbury DHB

Context

Myelosuppression Post RIC SCT/DLI

Patients with myelosuppression secondary to DLI should be managed as follows:

About this Canterbury DHB document (8892):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 8892